Biosettia focuses on the development and commercialization of unique technologies to provide better solutions for life science research. The company endeavors to provide innovative tools and specialty reagents to aid in genome-wide functional analysis and generation of induced pluripotent stem cells (iPSC). These include single-strand RNAi technology, microRNA expression systems, normalized full-length cDNA libraries and lentiviral delivery systems. In addition to providing reagents and services to the many academic institutes, biotech and pharmaceutical companies we have extended our research and development efforts to the fields of stem cell research, identification of cancer biomarkers, and discovery of next generation drug targets